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Abstract 
Phagocytes, including macrophages, recognize phosphatidylserine exposed on apoptotic 
cells as an “eat me” signal. Milk Fat Globule EGF Factor VIII (MFG-E8) is secreted by one 
subset of macrophages, whereas Tim4, a type I-membrane protein, is expressed by another. 
These proteins bind tightly to phosphatidylserine on apoptotic cells and enhance their 
engulfment by macrophages. To study the contribution of these proteins to the engulfment 
of apoptotic cells, we established a mouse line that was deficient in the genes encoding 
MFG-E8 and Tim4. The null mutation of Tim4 impaired the ability of resident peritoneal 
macrophages, but not thioglycollate-elicited macrophages, to engulf apoptotic cells. Mice 
deficient in either MFG-E8 or Tim4 on the C57BL/6 background developed hardly any 
autoantibodies, but aged female mice deficient in both MFG-E8 and Tim4 developed 
autoantibodies in an age-dependent manner. TNFα is known to protect against systemic 
lupus erythematosus-type autoimmunity, while type I IFN accelerates the disease. Indeed, 
the administration of an anti-TNFα antibody or a reagent that stimulates the IFNα 
production [2,6,10,14-tetramethylpentadecane (TMPD; also known as pristane)] enhanced 
the production of autoantibodies in the MFG-E8- and Tim4-double-deficient mice. These 
results suggest that the double deficiency of Tim4 and MFG-E8, 
phosphatidylserine-binding proteins, can trigger autoimmunity and that TNFα and type I 
IFN regulate reciprocally the development of autoimmune disease. 
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Introduction 
Everyday, 108 cells in the human body undergo apoptotic cell death (1). At the same time, 
several billion red blood cells are produced, and an equal number of nuclei (pyrenocytes) is 
expelled from erythroblasts in this process (2). The dead cells and expelled nuclei must be 
swiftly removed to prevent them from releasing noxious materials. Failure to remove them 
appears to activate the immune system and lead to systemic lupus erythematosus 
(SLE)-type autoimmune diseases (3,4).  
Macrophages, which are professional phagocytes, are responsible for clearing apoptotic 
cells and pyrenocytes (1). Macrophages recognize phosphatidylserine exposed on the 
plasma membranes of the dead cells and pyrenocytes as an “eat me” signal, and engulf 
them for degradation in the lysosomes (5,6). We and others previously identified several 
molecules that bind phosphatidylserine prior to resulting in the engulfment of apoptotic 
cells (6-11). Among them, MFG-E8 (Milk Fat Globule EGF Factor VIII) is a soluble 
protein secreted from a subset of macrophages and immature dendritic cells, including 
thioglycollate-elicited peritoneal macrophages, GM-CSF-induced bone marrow-derived 
dendritic cells, and Langerhans cells in the skin (12). MFG-E8 acts as bridge between dead 
cells and phagocytes, binding to phosphatidylserine on apoptotic cells and to integrins αvβ3 
or αvβ5 on macrophages or immature dendritic cells (10).  
Tim (T-cell immunoglobulin- and mucin-domain-containing)-4 is a type I membrane 
protein that is expressed by other subsets of macrophages, including resident peritoneal 
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macrophages and splenic MOMA-1+-marginal zone macrophages (11,13). Tim4 binds 
tightly to phosphatidylserine in vitro and supports the engulfment of apoptotic cells when 
expressed in mouse NIH3T3 cells.  
We previously showed that MFG-E8-deficient mice on a 129/B6-mixed background 
produce autoantibodies and suffer from autoimmune diseases (14). On the other hand, two 
groups recently showed that Tim4-deficient mice on the 129 or B6-background developed 
little or no autoimmunity (13,15). To clarify the role of MFG-E8 and Tim4, here we 
established a mouse line deficient in the genes for both MFG-E8 and Tim4 on the 
B6-background. Mice deficient in either MFG-E8 or Tim4 did not develop autoantibodies. 
In contrast, the MFG-E8/Tim4-double deficient mice developed a high level of 
autoantibodies, and this process was accelerated by the administration of an anti-TNFα 
neutralizing antibody or the hydrocarbon oil 2,6,10,14-tetramethylpentadecane (TMPD; 
also known as pristane) that stimulates type I IFN production. These results suggested that 
mice deficient in both MFG-E8 and Tim4, expressed in different sets of the macrophages, 
may generate sufficient numbers of unengulfed apoptotic cells to activate the autoimmunity, 




C57BL/6 mice were from Japan SLC (Shizuoka, Japan). CAD-/- mice were described (16). 
MFG-E8-/- mice generated from a 129 ES cell line (14), were backcrossed to the C57BL/6 
mice eight times. Tim4-/- MFG-E8-/- mice were generated by crossing Tim4+/- MFG-E8-/- 
mice. All mice were housed in a specific pathogen-free facility at Kyoto University 
Graduate School of Medicine. All animal experiments were carried out in accordance with 
protocols approved by the Kyoto University Animal Care and Use Committee. 
 
Monoclonal antibodies and reagents 
To produce an mAb against Tim4, Armenian hamsters were immunized with Tim4-Fc, in 
which the extracellular region of mouse Tim4 was joined to human IgG Fc region (11). 
Lymphocytes from the immunized hamsters were fused with a mouse myeloma NSObcl2 
(17). One hybridoma (Mat4-9-5) that was suitable for immunohistochemical staining, 
FACS analysis, immunoprecipitation, Western blotting, and neutralization of the 
engulfment was grown in serum-free GIT medium (Nihon Pharmaceutical, Tokyo, Japan), 
and the secreted mAb was purified using Protein A-Sepharose. The hamster Kat5-18 mAb 
was described (11). A rat anti-TNFα mAb (clone: MP6-XT22) (18) was produced by 
culturing the hybridoma in GIT medium, and purified by fractionation with 
(NH4)2SO3-precipitation. A leucine zipper-containing human Fas ligand (FasL) was 
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prepared in 293T cells, and partially purified as described (19). 
 
Targeted disruption of the Tim4 gene 
The Tim4-targeted mice were generated as custom order by Unitech (Kashiwa, Chiba, 
Japan). In brief, the Tim4 chromosomal gene was isolated from BAC clones of C57BL/6 
mice, and its exon 1 and most of exon 2 were replaced by a coding sequence for Venus and 
neo gene (Fig. 1). To increase the efficiency of homologous recombination, a coding 
sequence for the diphtheria toxin A fragment (DT-A) was inserted downstream of exon 5 in 
the targeting vector. The targeting vector was transfected into ES cells (clone: Bruce 4) 
derived from C57BL/6 mice (20). The ES clones carrying the Tim4-deficient allele were 
introduced into host embryos, and chimeric mice were produced. The chimeric mice with a 
high ES cell contribution were crossed with C57BL/6 mice to obtain heterozygous 
Tim4-deficient mice.  
The genotype of the Tim4 and MFG-E8 genes was determined by PCR using TaKaRa 
LA Taq (Takara Bio, Kyoto, Japan) or Taq DNA polymerase from Ampliqon (Skovlunde, 
Denmark). For the wild-type and mutant alleles of the Tim4 gene, a sense primer specific 
for the wild-type (5’-ATTGAGGGAGGTCATTCAGGA-3’) or mutant allele 
(5’-GACCCTGAAGCTGATCTGCA-3’) was used with a common antisense primer 
(5’-AGCGCACATTCTTCTTGACA-3’). The wild-type and mutant alleles of the MFG-E8 
gene were detected by a similar method using the wild-type 
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(5’-CTTTGGAGGATGTACACAGA-3’) or mutant 
(5’-CGTGGGATCATTGTTTTTCT-3’) specific sense primer and the common antisense 
primer (5’-CTTTATGTACTGTGCCTCCA-3’).   
 
Administration of pristane and anti-TNFα monoclonal antibody. 
Female mice at 7-10 weeks of age were injected i.p. with 0.5 ml Pristane (Sigma-Aldrich, , 
St. Louis, MO) as described (21), while the anti-TNFα mAb or control rat IgG (200 
µg/head) was administered twice a week by i.p. injection as described (22).   
 
Isolation of tissue macrophages 
Resident and thioglycollate-elicited peritoneal macrophages were isolated from female 
C57BL/6 mice at 6 weeks of age as described (10,11). Alveolar macrophages were 
prepared from the lungs by bronchoalveolar lavage with PBS containing 0.5 mM EDTA, 
cultured on plastic dish for 2 h, and washed with PBS to remove non-adherent cells. 
Kupffer cells were prepared as described (23). In brief, the liver was perfused in situ at a 
flow rate of 5 ml/min for 5 min with prewarmed (37°C) Hank’s Balanced Salt Solution 
(HBSS, Invitrogen, Carlsbad, CA) containing 0.5 mM EGTA, then with HBSS containing 
1.8 mM CaCl2, 2.0 mM MgCl2, 1.0 mg/ml collagenase D, and 0.1 mg/ml DNase I for 5 min. 
The liver was removed and minced at 4°C with scissors in 10 ml HBSS. After filtrating 
through stainless steel mesh (diameter: 106 µm), the cell suspension was centrifuged at 50 
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x g for 1 min at 4°C to remove aggregates. The cells in the supernatant were collected by 
centrifugation at 280 x g for 10 min, and suspended in cold HBSS containing 10% FCS. 
The cells were then layered on 17% metrizamide (Sigma-Aldrich), and centrifuged at 1800 
x g for 30 min at 4°C. The cells at the interphase was collected, suspended in HBSS 
containing 10% FCS, and precipitated by centrifugation at 780 x g for 10 min. Cells were 
suspended in serum-free RPMI, cultured at 37°C for 15 min in non-coating dish (Iwaki, 
Chiba, Japan), and washed to remove non-adherent cells.   
 
Flow cytometry 
Cells were incubated on ice for 30 min with 1 µg/ml biotinylated Kat5-18 in 100 µl staining 
solution (PBS containing 2% FCS), followed by incubation with 2 µg/ml 
APC-Cy7-conjugated streptavidin (BD Bioscience, Franklin Lakes, NJ) and 2 µg/ml 
APC-conjugated anti-CD11b (BioLegend, San Diego, CA). The cells were then stained 
with 0.5 µM SYTOX Blue (Invitrogen) to exclude dead cells, and analyzed by flow 
cytometry with a FACSAria (BD Bioscience). 
 
Phagocytosis assay 
The engulfment of apoptotic cells was assayed by TUNEL staining with CAD-/- thymocytes 
as prey as described (10). In brief, 1 x 106 peritoneal cells were incubated in 12-well plates 
at 37°C for 2 h, and washed with PBS. Thymocytes from CAD-/- mice were induced to 
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undergo apoptosis by treatment with 4 units/ml FasL for 2 h, and 5 x 106 apoptotic cells 
were cultured at 37°C for 30 min with the peritoneal cells. After staining with 
APC-anti-CD11b, the cells were fixed with 1% paraformaldehyde, subjected to TUNEL 
staining with FITC-labeled dUTP (Roche Diagnostics, Indianapolis, IN), and analyzed by 
flow cytometry on a FACSAria (BD Biosciences). In some cases, 2 x 105 peritoneal cells 
were cultured in glass dishes (Iwaki) that had been coated with 1.0% gelatin. Mouse 
thymocytes were labeled with CellTrackerTM Orange (Invitrogen), treated with FasL as 
described above, and apoptotic cells (1 x 106) were co-incubated with resident peritoneal 
macrophages for 30 min. After staining with FITC-anti-CD11b, the cells were observed by 
fluorescence microscopy (BioRevo BZ-9000, Keyence, Osaka, Japan). 
 
Real-time PCR 
Total RNA was prepared using ISOGEN (NIPPON GENE, Tokyo, Japan), followed by 
RNeasy Micro Kit (QIAGEN, Hilden, Germany), and was reverse-transcribed using 
Superscript III (Invitrogen). Aliquots of the products were amplified in a reaction mixture 
containing LightCyclerTM 480 SYBR Green I Master (Roche Diagnostics). The primers 
used for real-time PCR were as follows. Tim4, 5’-GGCTCCTTCTCACAAGAAACCACA 
and 5’-TCAGCTGTGAAGTGGATGGGAGA; MFG-E8, 
5’-GATCTTTCCAACAACCTAGCCTCC and 5’-ACCGCTTTCATCCTGGATGAACTC; 




The serum level of anti-dsDNA antibodies and anti-nuclear antibodies (ANA) was 
determined as described (24). In brief, for the anti-dsDNA, the linearized plasmid DNA (5 
µg/ml) was immobilized on NucleoLink plates (Nalge Nunc, Rochester, NY) by treating it 
at 50°C for 5 h with 10 mM 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide in 10 mM 
1-methylimidazole. The plates were washed with 5 x SSC containing 0.25% SDS, and 
nonspecific binding sites were blocked with 1% BSA in PBS. The serum was diluted to the 
appropriate concentration, added to the wells, and incubated at room temperature for 1 h. 
After washing with PBS containing 0.1% Tween 20, the concentration of autoantibodies 
bound to each well was quantified by ELISA with AP-conjugated rabbit anti-mouse Ig 
(Dako, Copenhagen, Denmark). Phosphatase activity was detected using the BluePhos 
Microwell Phosphatase Substrate System (KPL, Gaithersburg, MA) and quantified by 
measuring the absorbance at 620 nm. The ANA level was determined using the Mesacup 
EIA system from MBL (Nagoya, Japan) for human ANA, except that the HRP-conjugated 
goat anti-human Ig was replaced by AP-conjugated rabbit anti-mouse Ig and the plate was 




Requirement of Tim4 by peritoneal macrophages for the engulfment of apoptotic cells 
In addition to Tim4 and MFG-E8, several molecules, such as BAI1, stabillin-2, Tim1, and 
Tim3 are reported to recognize phosphatidylserine and mediate the engulfment of apoptotic 
cells (8,9,11,25). We previously showed that MFG-E8 and Tim4 are rather 
complementarily expressed in different sets of macrophages. That is, Tim4 is expressed in 
resident peritoneal macrophages, while MFG-E8 is expressed in thioglycollate-elicited 
peritoneal macrophages (11). This was further confirmed with other tissue macrophages. 
Alveolar macrophages expressed MFG-E8 but not Tim4, while Kupffer cells expressed 
Tim4 but not MFG-E8 (Supplementary Fig. 1).  
We previously established MFG-E8-null mice, and showed that MFG-E8 is required 
for the efficient engulfment of apoptotic cells in vitro by thioglycollate-elicited 
macrophages, and in vivo by the tingible-body macrophages in the spleen (14). To examine 
the role of Tim4 in the engulfment of apoptotic cells by a distinct set of macrophages, we 
established a Tim4-deficient mouse line (Fig. 1A). As shown in Figure 1B, about 40-50% 
of the cells in the mouse peritoneum was strongly stained with CD11b, and most of them 
expressed Tim4. As expected, the peritoneal cells from Tim4-null mice did not stain with 
anti-Tim4 mAb. When resident peritoneal macrophages were co-incubated with apoptotic 
thymocytes, they efficiently engulfed them (Fig. 2). The Tim4-null mutation almost 
completely abolished this ability. In agreement with MFG-E8 not being expressed in 
 12 
resident peritoneal macrophages (11), the null-mutation of the MFG-E8 gene did not have 
any effect on these cells’ ability to engulf apoptotic cells. These results indicated that Tim4 
plays an indispensable role in the engulfment of apoptotic cells in resident peritoneal 
macrophages. 
 
Synergistic effect of MFG-E8 and Tim4 on the development of autoimmunity.  
We previously established MFG-E8-null mice in a 129/B6 mixed background and showed 
that they, in particular the females, age-dependently developed an SLE-type autoimmunity 
(14). On the other hand, when mice bearing this mutation were back-crossed to C57BL/6 
mice more than 8 times, this phenotype and the level of autoantibodies in the serum were 
significantly reduced (Fig. 3). Recently, two groups established Tim4-null mice in the 129 
and B6 mouse strains, respectively. The Tim4-null mice on the 129 background do not 
produce autoantibodies (13), but those on the B6 background produce a low but significant 
level of them (15).  
As shown in Figure 3, the Tim4-null mice that we established on the B6 background 
did not produce a significant level of autoantibodies (anti-dsDNA or ANA). We previously 
reported that the injection into B6 mice of recombinant MFG-E8 mutant (D89E), which 
masks the phosphatidylserine on apoptotic cells, causes strong autoimmunity (26). As 
discussed above, Tim4 and MFG-E8 are expressed in distinct sets of macrophages and 
probably function non-redundantly. We therefore examined whether mice bearing double 
 13 
knockout mutations of the MFG-E8 and Tim4 genes would exhibit any effect on the 
development of autoimmunity. As shown in Figure 3, no autoantibodies (anti-ds DNA or 
ANA) were found in the serum of the MFG-E8/Tim4-double deficient mice at 10 weeks of 
age. On the other hand, by 30 weeks of age, the female MFG-E8/Tim4-double deficient 
mice developed a significant level of autoantibodies. These results suggested that the dose 
of unengulfed apoptotic cells generated by the lack of either the Tim4 or MFG-E8 gene 
alone, but not by their double deficiency, might be insufficient to trigger the development 
of autoimmunity.   
 
Reciprocal regulation of the autoimmunity by TNFα  and type I IFN  
Previous studies by a number of groups showed that an SLE-type autoimmunity is 
reciprocally regulated by TNFα and type I IFN in mouse and human (27-31). That is, 
blocking the circulating TNFα or increasing IFNα level in the serum accelerates the 
development of the disease. To examine whether or not TNFα has any effects on the 
regulation of the SLE-type disease in the Tim4-/-, MFG-E8-/- and Tim4-/-MFG-E8-/- mice, a 
TNFα-neutralizing mAb was administered twice a week to these mice. As shown in Figure 
4, a significant level of anti-dsDNA antibodies could be detected even in the serum of Tim4 
or MFG-E8-single null mice after 6 weeks, and an enhanced synergistic effect on the 
development of the autoimmunity was observed in the double MFG-E8/Tim4-deficient 
mice. While, rat control IgG had no effect on autoimmunity in Tim4-/- mice (data not 
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shown). These results confirmed that the constitutive exposure to TNFα prevented the 
development of autoimmunity in these mice.  
When pristane is introduced into mouse peritoneal cavity, it stimulates the production 
of type I IFN in a TLR-dependent manner, causing chronic inflammation (32). To examine 
the effect of type I IFN on the development of the autoimmune disease in Tim4-/-, 
MFG-E8-/- and Tim4-/-MFG-E8-/- mice, pristane was injected i.p into these mice at 7-10 
weeks of age. As shown in Figure 4B, a high level of anti-dsDNA could be detected at 7 
week after the pristane-injection in the Tim4-/-MFG-E8-/- double-deficient mice. These data 
suggested that the pristane-induced inflammation, probably type I IFN system, accelerated 
the production of the autoantibody in Tim4-/-MFG-E8-/- mice.  
 15 
Discussion 
A failure of the efficient engulfment of apoptotic cells has been believed to cause 
autoimmune disease, because noxious materials are released from unengulfed dead cells 
that undergo secondary necrosis (1,33). Many molecules have been proposed to regulate the 
engulfment of apoptotic cells, and mice with a deficiency of MER (a tyrosine kinase 
receptor) developed a severe autoimmune response, including splenomegaly, proteinuria, 
and elevated autoantibodies (34). Here, we showed that, although a single deficiency of the 
MFG-E8 or Tim4 gene did not activate autoimmunity in the B6 mouse strain, the 
double-deficiency of the Tim4 and MFG-E8 genes did. This finding is different from our 
previous one showing that MFG-E8-null mice develop autoimmunity (14). We now 
attribute this observation to the mixed 129/B6 background of the MFG-E8-null mice that 
we analyzed in the earlier study, because the mouse strain of 129 and B6 chimeric 
background often spontaneously develops autoimmunity (35). The experiments in this 
report were therefore performed with MFG-E8-null mice that were backcrossed at least 8 
times to B6 mice. Our results also do not agree with Rodriguez-Manzanet et al (15), which 
showed a significant development of autoantibodies in Tim4-null mice on the B6 
background. Because SLE-type autoimmunity is greatly influenced not only by genetics but 
also by environmental factors (36), it is possible that, although our mice and those studied 
by Rodriguez-Manzanet et al (15) were kept under specific pathogen-free conditions, some 
small difference in the environment might result in a different outcome in the development 
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of the autoimmunity.  
In any case, we showed here that the double mutation of the MFG-E8 and Tim4 genes 
activated autoimmunity with high frequency. MFG-E8 and Tim4 are expressed in different 
sets of macrophages, and are required for the engulfment of apoptotic cells differentially 
among macrophages. Tim4 was reported to stimulate proliferation of T cells (37). However, 
no apparent abnormality (splenomegaly, lymphadenopathy, or lymphopenia) was observed 
in the Tim4-null mutation. We also did not observe unengulfed apoptotic cells in Tim4-,  
MFG-E8-, and MFG-E8/Tim4-double deficient mice. Whereas, our preliminary analysis of 
the dexamethasone-treated mice suggested that the MFG-E8/Tim4-double deficient mice 
may have the reduced ability to clear apoptotic thymocytes (K.S. and S.N., unpublished 
observations). Thus, although a possibility that the abnormal T cell development caused by 
the Tim4-deficiency enhances the autoimmunity cannot be ruled out, we postulate that the 
double mutations of the Tim4 and MFG-E8 genes may generate a higher dose of 
unengulfed apoptotic cells that can be immunogenic. This  appears to agree with the 
hypothesis that autoimmunity develops only when the determining “factors” for SLE reach 
a certain threshold (38).  
Resident peritoneal macrophages express Tim4, and require Tim4 to engulf apoptotic 
cells. MER is also expressed in mouse resident peritoneal macrophages, and seems to be 
indispensable for this ability (39), suggesting that Tim4 and MER co-operate in the 
engulfment of apoptotic cells. On the other hand, tingible body macrophages in the spleen 
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express Tim4, MFG-E8, and MER, although MFG-E8 and MER, but not Tim4, seem to be 
required for the engulfment of apoptotic cells by tingible body macrophages (40). However, 
it is not clear how MFG-E8, Tim4 and MER in different macrophages trigger the 
engulfment of apoptotic cells. To fully understand the molecular mechanism for the 
recognition of apoptotic cells, it will be necessary to reconstitute the engulfment system 
with these and other phosphatidylserine-binding proteins.  
TNFα is a pleiotropic cytokine with many physiological and pathological functions (41). 
It is responsible for the inflammation caused by endotoxin-induced septic shock and 
rheumatoid arthritis. On the other hand, the chronic exposure of mice to a low level of 
TNFα suppresses immune reactions, for example by inhibiting cytokine production from T 
cells and activating regulatory T cells (42). The administration of an anti-TNFα mAb to 
human patients with rheumatoid arthritis sometimes triggers an SLE-type autoimmune 
disease (43). Similarly, the administration of the anti-TNFα mAb accelerated the 
development of autoantibodies in MFG-E8-, Tim4-, and MFG-E8/Tim4-double deficient 
mice, supporting the previous report that TNFα inhibits the development of SLE (44). 
Tim4-/- macrophages were reported to produce TNFα constitutively (13). Although we 
could not detect the difference in the serum TNFα level between the wild-type and Tim4-/- 
mice (data not shown), it is possible that the local chronic exposure of the Tim4-/- immune 
system to a low concentration of TNFα may explain the difference between the lack of 
autoantibody production in Tim4-/- mice and the strong autoantibody production in adult 
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mice treated with an anti-Tim4 mAb (11). The 3’-non coding region of TNFα, which has a 
regulatory role in its gene expression, shows a strong polymorphism among mouse strains, 
which may explain the different susceptibilities of various MFG-E8-null mouse strains to 
autoantibody production.  
IFNα, a type I IFN, has recently been recognized as a critical mediator of human SLE 
(30,31). Administration of pristane into mice induces the IFN gene expression leading to 
the development of SLE-type autoimmune disease in a Toll-like receptor 
(TLR)7-dependent manner (21). TLR7 is a receptor for nucleic acids. Since the mutations 
(lpr and gld) in Fas and Fas ligand that are involved in the activation-induced cell death of 
lymphocytes (45) reduces the pristane-induced SLE phenotype (46), it is believed that the 
nucleic acids released from dead cells trigger the disease (32). The accelerated development 
of the pristane-induced autoimmunity in Tim4-/-MFG-E8-/- mice may support the idea that 
the lack of Tim4 and MFG-E8 generates more unengulfed dead cells, which undergo 
secondary necrosis to release nucleic acids. Ninety percent of human SLE patients are 
female (47), and an involvement of female hormone is considered to play a role. Like 
human patients, the SLE phenotype in Tim4-/-MFG-E8-/- mice is prevalent in female, 
indicating that the Tim4/MFG-E8-null mice developed for this report may be useful for 
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Legends to Figures 
Fig. 1. Establishment of Tim4-deficient mice. (A) Targeting of the Tim4 gene. Schematic 
representation of the wild-type and mutant loci of the Tim4 gene and the targeting vector. 
Exons are represented by closed boxes. The targeting vector carries the neomycin 
resistance gene (neo) and the gene encoding the Diphtheria toxin A fragment (DT-A). (B) 
Expression of Tim4 in Mac-1+ peritoneal cells. Peritoneal cells from the wild-type and 
Tim4-deficient mice were stained with biotin-labeled anti-Tim4 followed by 
APC-Cy7-streptoavidin and APC-CD11b, and analyzed on a FACSAria. 
 
Fig. 2. Phagocytosis of apoptotic cells by resident peritoneal macrophages. (A) Resident 
peritoneal macrophages from wild-type, Tim4-/-, MFG-E8-/- and Tim4-/-MFG-E8-/- mice 
were incubated at 37°C for 30 min with apoptotic CAD-/- thymocytes, and the phagocytosis 
was assayed by TUNEL staining followed by FACS analysis. The percentage of 
TUNEL-positive cells in the Mac-1+ population is plotted. (B) Resident peritoneal 
macrophages from wild-type, Tim4-/-, MFG-E8-/- and Tim4-/-MFG-E8-/- mice were 
incubated at 37°C for 30 min with CelltrackerTM Orange-labeled-apoptotic thymocytes, 
washed with PBS, stained with FITC-anti-CD11b, and observed by fluorescence 
microscopy.  
 
Fig. 3. Production of autoantibodies in MFG-E8-/-Tim4-/- mice. The concentration of the 
 27 
anti-dsDNA antibody (A and B) and ANA (C and D) was determined for the male and 
female mice of the wild-type, Tim4-/-, MFG-E8-/-, and Tim4-/-MFG-E8-/- genotypes at 10 (A 
and C) and 30 (B and D) weeks of age. The average value was determined for each group 
(more than 5 mice per group), and is shown as bar. The p-values between the indicated 
pairs are shown.   
 
Fig. 4. Enhanced production of the autoantibodies. (A) Effect of anti-TNFα mAb on the 
autoantibody production. Wild-type, Tim4-/-, MFG-E8-/-, and Tim4-/-MFG-E8-/- female mice 
(5 mice each) at 7-11 weeks of age were injected i.p. twice a week with the anti-TNFα 
mAb (200 µg per head). Before the injection (0 weeks) and at 2, 4, and 6 weeks after the 
injection, the anti-dsDNA antibody level of the serum was determined. The average values 
are indicated by horizontal bars, and the p-values for the differences between the indicated 
pairs are shown. (B) Effect of pristane on the autoantibody production. Wild-type, Tim4-/-, 
MFG-E8-/-, and Tim4-/-MFG-E8-/- female mice (5-7 mice each) at 7-10 weeks of age were 
injected i.p. with pristane (0.5 ml per head). Before and at 7 weeks after the injection, the 
serum was collected, and the level of the anti-dsDNA antibody was determined. Bars 
indicate the mean values.  
 
Supplemental Fig. 1. Expression of Tim4 and MFG-E8 in different macrophages. RNA 
was prepared from the resident peritoneal macrophage, thioglycollate-elicited peritoneal 
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macrophage, alveolar macrophage, and Kupffer cells. The mRNA level for MFG-E8 and 
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